In preclinical studies, BPC-157 has shown a favorable safety profile
Researchers attribute these effects to Epithalons ability to restore normal p53 tumor suppressor gene expression, reduce oncogene activity, and re-normalize the cell cycle checkpoints that become dysregulated in aging tissues
However, serious adverse effects have been reported, including risk for C-cell tumors, acute pancreatitis, acute gallbladder disease, hypoglycemia, elevated heart rate, renal impairment, hypersensitivity reactions, and suicidal behavior and ideation
Therefore, patients who have existing insurance coverage for brand name Wegovy or Zepbound will not be able to utilize Ellie MD services since it does not accept insurance coverage
Cell 184 , 44954511.e19 (2021)